Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Kyle Rove to Male

This is a "connection" page, showing publications Kyle Rove has written about Male.

 
Connection Strength
  
 
 
0.673
  
  1. Chan M, Blanchette E, Rove KO. Pediatric Patients Undergoing Enterocystoplasty and Risk of Metabolic Disease: A Single Center Retrospective Study. Neurourol Urodyn. 2026 Jan; 45(1):225-230.
    View in: PubMed
    Score: 0.035
  2. Mansfield SA, Kotagal M, Hartman SJ, Murphy AJ, Hogan B, Ha D, Anghelescu DL, Mecoli M, Cost NG, Davidoff AM, Rove KO. Enhanced Recovery After Surgery (ERAS) Improves Length of Stay and Decreases Complications After Resection of Abdominal Neuroblastoma. Pediatr Blood Cancer. 2025 Nov; 72(11):e31971.
    View in: PubMed
    Score: 0.035
  3. Harris KT, Hwang C, Caldwell B, Vemulakonda V, Wood D, Wilcox DT, Rove KO. Use of incisional negative pressure wound therapy in reconstructive pediatric and young adult urology to reduce surgical site occurrences: A pilot study. J Pediatr Urol. 2025 Oct; 21(5):1306-1312.
    View in: PubMed
    Score: 0.034
  4. Ha D, Russell N, Olson KE, Whitney GM, Kulungowski AM, McCourt E, Rove KO. Gender Differences in Electronic Health Record Inbox Message Volumes Among Pediatric Surgeon Specialists. J Pediatr Surg. 2025 Apr; 60(4):162191.
    View in: PubMed
    Score: 0.033
  5. Meier KM, Ha D, Sevick C, Blanchette ED, Brockel MA, Vemulakonda VM, Rove KO. Opioid prescribing patterns and the effect of chronic kidney disease in pediatric urology population: A retrospective cohort analysis. J Pediatr Urol. 2025 04; 21(2):460-469.
    View in: PubMed
    Score: 0.033
  6. Mansfield SA, Kotagal M, Hartman SJ, Murphy AJ, Davidoff AM, Hogan B, Ha D, Anghelescu DL, Mecoli M, Cost NG, Rove KO. Enhanced Recovery After Surgery for Pediatric Abdominal Tumor Resections: A Prospective Multi-institution Study. J Pediatr Surg. 2025 Feb; 60(2):162046.
    View in: PubMed
    Score: 0.033
  7. Ha D, Halstead NV, Blanchette ED, Wilcox DT, Vemulakonda VM, Wood DN, Rove KO. Risk of acute kidney injury after lower urinary tract reconstruction with early NSAID therapy: A propensity matched retrospective analysis. J Pediatr Urol. 2024 10; 20(5):911-920.
    View in: PubMed
    Score: 0.032
  8. Meier KM, Mata C, Kaar JL, Rensing AJ, Dudley AG, Carrasco A, Drzewiecki BA, VanderBrink BA, Streur CS, Bagli DJ, Chalmers DJ, Wilcox DT, Yerkes EB, Lau GA, Vricella GJ, Hecht SL, Copp HL, Pohl HG, Franco I, Ahn J, Wiener JS, Singer JS, Long CJ, Keays MA, Daugherty MR, Fuchs ME, Austin PF, Wu CQ, Zee RS, Misseri R, Tanaka ST, Bauer SB, Rove KO. Expert Consensus on Pediatric Urodynamics Reporting Using Modified Delphi Technique. J Urol. 2024 07; 212(1):165-174.
    View in: PubMed
    Score: 0.032
  9. Han DS, Brockel MA, Boxley PJ, Dönmez MI, Saltzman AF, Wilcox DT, Rove KO. Enhanced recovery after surgery and anesthetic outcomes in pediatric reconstructive urologic surgery. Pediatr Surg Int. 2021 Jan; 37(1):151-159.
    View in: PubMed
    Score: 0.025
  10. Rove KO, Vricella GJ, Hershey T, Thu MH, Lugar HM, Vetter J, Marshall BA, Austin PF. Lower Urinary Tract Dysfunction and Associated Pons Volume in Patients with Wolfram Syndrome. J Urol. 2018 11; 200(5):1107-1113.
    View in: PubMed
    Score: 0.021
  11. Rove KO, Brockel MA, Saltzman AF, Dönmez MI, Brodie KE, Chalmers DJ, Caldwell BT, Vemulakonda VM, Wilcox DT. Prospective study of enhanced recovery after surgery protocol in children undergoing reconstructive operations. J Pediatr Urol. 2018 06; 14(3):252.e1-252.e9.
    View in: PubMed
    Score: 0.021
  12. Rove KO, Warncke JC, Vemulakonda VM. Trends in pediatric urologic consultations in a tertiary care hospital setting. J Pediatr Urol. 2018 02; 14(1):12.e1-12.e8.
    View in: PubMed
    Score: 0.020
  13. Rove KO, Maroni PD, Cost CR, Fairclough DL, Giannarini G, Harris AK, Schultz KA, Cost NG. Pathologic Risk Factors for Metastatic Disease in Postpubertal Patients With Clinical Stage I Testicular Stromal Tumors. Urology. 2016 11; 97:138-144.
    View in: PubMed
    Score: 0.019
  14. Rove KO, Maroni PD, Cost CR, Fairclough DL, Giannarini G, Harris AK, Schultz KA, Cost NG. Pathologic Risk Factors in Pediatric and Adolescent Patients With Clinical Stage I Testicular Stromal Tumors. J Pediatr Hematol Oncol. 2015 Nov; 37(8):e441-6.
    View in: PubMed
    Score: 0.018
  15. Rove KO, Crawford ED, Perachino M, Morote J, Klotz L, Lange PH, Andriole GL, Matsumoto AM, Taneja SS, Eisenberger MA, Reis LO. Maximal testosterone suppression in prostate cancer--free vs total testosterone. Urology. 2014 Jun; 83(6):1217-22.
    View in: PubMed
    Score: 0.016
  16. Rove KO, Crawford ED. Traditional androgen ablation approaches to advanced prostate cancer: new insights. Can J Urol. 2014 Apr; 21(2 Supp 1):14-21.
    View in: PubMed
    Score: 0.016
  17. Rove KO, Crawford ED. Androgen annihilation as a new therapeutic paradigm in advanced prostate cancer. Curr Opin Urol. 2013 May; 23(3):208-13.
    View in: PubMed
    Score: 0.015
  18. Crawford ED, Rove KO. Advanced prostate cancer: therapeutic sequencing, outcomes, and cost implications. Am J Manag Care. 2012 12; 18(5 Spec No.):SP250-3.
    View in: PubMed
    Score: 0.014
  19. Rove KO, Debruyne FM, Djavan B, Gomella LG, Koul HK, Lucia MS, Petrylak DP, Shore ND, Stone NN, Crawford ED. Role of testosterone in managing advanced prostate cancer. Urology. 2012 Oct; 80(4):754-62.
    View in: PubMed
    Score: 0.014
  20. Rove KO, Crawford ED. Editorial comment. J Urol. 2012 Jun; 187(6):2049; discussion 2050.
    View in: PubMed
    Score: 0.014
  21. Rove KO, Crawford ED. Evolution of treatment options for patients with CRPC and bone metastases: bone-targeted agents that go beyond palliation of symptoms to improve overall survival. Oncology (Williston Park). 2011 Dec; 25(14):1362-70, 1375-81, 1387.
    View in: PubMed
    Score: 0.013
  22. Rove KO, Crawford ED. Randomized controlled screening trials for prostate cancer using prostate-specific antigen: a tale of contrasts. World J Urol. 2012 Apr; 30(2):137-42.
    View in: PubMed
    Score: 0.013
  23. Rove KO, Crawford ED. Dutasteride: novel milestones in prostate cancer chemoprevention. Drugs Today (Barc). 2011 Feb; 47(2):135-44.
    View in: PubMed
    Score: 0.013
  24. Rove KO, Flaig TW. A renaissance in the medical treatment of advanced prostate cancer. Oncology (Williston Park). 2010 Dec; 24(14):1308-13, 1318.
    View in: PubMed
    Score: 0.013
  25. Crawford ED, Rove KO. Incomplete testosterone suppression in prostate cancer. N Engl J Med. 2010 Nov 11; 363(20):1976.
    View in: PubMed
    Score: 0.013
  26. Rove KO, Sullivan KF, Crawford ED. High-intensity focused ultrasound: ready for primetime. Urol Clin North Am. 2010 Feb; 37(1):27-35, Table of Contents.
    View in: PubMed
    Score: 0.012
  27. Edwards MH, Nicklawsky A, Beltran G, Stein E, Pyrzanowski J, Rove K, Boone K, Milgrom S, Cost NG. Effect of Pelvic External Beam Radiation Therapy on Lower Urinary Tract Function of Pediatric Patients. Pediatr Blood Cancer. 2025 Nov; 72(11):e31996.
    View in: PubMed
    Score: 0.009
  28. Tasian GE, Chu DI, Nelson CP, DeFoor WR, Ziemba JB, Huang J, Luan X, Kurtz M, Ching CB, Dangle P, Schaeffer AJ, Sturm R, Wu W, Bayne C, Fernandez N, Chua ME, DeMarco R, Ellsworth P, Augelli B, Bi-Karchin J, McCune RD, Vatsky S, Back S, Wang Z, Beck H, Kurth A, Kurth L, Pleskoff A, Forrest CB, Ellison JS, Rove K, Sparks S, Nelson E, Schlomer B, Krill A, Tong CMC, Taylor A, Ramachandra P, Stec A, Casale P, Coplen D, Janzen N, Bagley K, Denburg MR, Dickinson K, Laberee R, Lorenzo M, Selman-Fermin A, Dos Santos J, Grant C, Kraft K, Meenakshi-Sundaram B. Ureteroscopy vs Shockwave Lithotripsy to Remove Kidney Stones in Children and Adolescents: A Nonrandomized Clinical Trial. JAMA Netw Open. 2025 Aug 01; 8(8):e2525789.
    View in: PubMed
    Score: 0.009
  29. Finkelstein JB, Weber B, Quigley S, De S, Zann A, Rove K, Liebrecht D, Zee R, Chan Y, Battie S, Pohl H, Carmen Tong CM, Dudley A, McQuiston L, Durkin ET, Davis TD, Whitehouse J, Polsky E, Killian M, Wu HY, Gong E, Chalmers D, Figueroa TE, Grimsby G, Fernandez N, Ballesteros N, Saito JM, Metcalfe P, Schober M, Lambert S, Grant C, Ellison JS. Leveraging NSQIPP testicular torsion process measures: Initial survey of the NSQIPP testicular torsion collaborative. J Pediatr Urol. 2025 Dec; 21(6):1844-1850.
    View in: PubMed
    Score: 0.009
  30. Alzate-Ricaurte S, Gallego EDA, De la Torre L, Costa-Roig A, Hwang C, Harris KT, Wilcox DT, Rove KO, Bischoff A. Role of urodynamics in predicting fecal incontinence in spina bifida and spinal cord injury patients. Pediatr Surg Int. 2025 Jun 07; 41(1):159.
    View in: PubMed
    Score: 0.009
  31. Ellison JS, Chu DI, Nelson CP, DeFoor WR, Ziemba J, Huang J, Luan X, Kurtz M, Ching CB, Dangle PP, Schaeffer AJ, Sturm R, Wu W, Bayne C, Fernandez N, Chua ME, DeMarco R, Ellsworth P, Augelli B, Bi-Karchin J, McCune RD, Vatsky S, Back S, Wang Z, Beck H, Kurth A, Kurth L, Pleskoff A, Forrest CB, Tasian GE, Rove K, Sparks S, Nelson E, Schlomer B, Krill A, Tong CMC, Taylor A, Ramachandra P, Stec A, Casale P, Coplen D, Janzen N, Bagley K, Denburg M, Dickinson K, Laberee R, Lorenzo M, Selman-Fermin A, Dos Santos J, Grant C, Kraft K, Meenakshi-Sundaram B. Percutaneous Nephrolithotomy vs Ureteroscopy for Kidney Stones in Children. JAMA Netw Open. 2025 06 02; 8(6):e2516749.
    View in: PubMed
    Score: 0.009
  32. Kong L, Sevick C, Beltran G, Rove K, Wilcox D, Hecht S. Caregiver decisional regret following reconstructive bladder surgery in children with neurogenic bladder. J Pediatr Urol. 2024 12; 20(6):1134-1141.
    View in: PubMed
    Score: 0.008
  33. Jáuregui EJ, Diala O, Rove KO, Hoefner-Notz R, Tong S, Nguyen T, Friedman NR. Overnight Monitoring Criteria for Children with Obstructive Sleep-Disordered Breathing After Tonsillectomy: Revisited. Laryngoscope. 2024 12; 134(12):5223-5230.
    View in: PubMed
    Score: 0.008
  34. Ching CB, Dickinson K, Karafilidis J, Marchesani N, Mucha L, Antunes N, Razzaghi H, Utidjian L, Yonekawa K, Coplen DE, Muneeruddin S, DeFoor W, Rove KO, Forrest CB, Tasian GE. The real world experience of pediatric primary hyperoxaluria patients in the PEDSnet clinical research network. Eur J Pediatr. 2023 Sep; 182(9):4027-4036.
    View in: PubMed
    Score: 0.008
  35. Tasian GE, Maltenfort MG, Rove K, Ching CB, Ramachandra P, DeFoor B, Fernandez N, Forrest CB, Ellison JS. Ureteral Stent Placement Prior to Definitive Stone Treatment Is Associated With Higher Postoperative Emergency Department Visits and Opioid Prescriptions for Youth Having Ureteroscopy or Shock Wave Lithotripsy. J Urol. 2023 06; 209(6):1194-1201.
    View in: PubMed
    Score: 0.007
  36. Chan YY, Rosoklija I, Meade P, Burjek NE, Raval MV, Yerkes EB, Rove KO, Chu DI. Utilization of and barriers to enhanced recovery pathway implementation in pediatric urology. J Pediatr Urol. 2021 06; 17(3):294.e1-294.e9.
    View in: PubMed
    Score: 0.006
  37. Weaver J, Rove KO, Vricella GJ. Extra-adrenal Pheochromocytoma Associated With Segmental Renal Artery Compression and Pseudostenosis. Urology. 2018 Oct; 120:238-240.
    View in: PubMed
    Score: 0.005
  38. Ballard DH, Rove KO, Coplen DE, Chen TY, Hulett Bowling RL. Fibroepithelial polyp causing urethral obstruction: Diagnosis by cystourethrogram. Clin Imaging. 2018 Sep - Oct; 51:164-167.
    View in: PubMed
    Score: 0.005
  39. Okland T, Karimkhani C, Pederson H, Boyers LN, Sawyer MD, Rove KO, Kenny MC, Steinberg S, Naghavi M, Dellavalle RP. Research prioritization of men's health and urologic diseases. Int Braz J Urol. 2017 Mar-Apr; 43(2):289-303.
    View in: PubMed
    Score: 0.005
  40. Chalmers DJ, Rove KO, Wiedel CA, Tong S, Siparsky GL, Wilcox DT. Clean intermittent catheterization as an initial management strategy provides for adequate preservation of renal function in newborns with persistent cloaca. J Pediatr Urol. 2015 Aug; 11(4):211.e1-4.
    View in: PubMed
    Score: 0.004
  41. Crawford ED, Rove KO, Barqawi AB, Maroni PD, Werahera PN, Baer CA, Koul HK, Rove CA, Lucia MS, La Rosa FG. Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens. Prostate. 2013 May; 73(7):778-87.
    View in: PubMed
    Score: 0.004
  42. Crawford ED, Rove KO, Trabulsi EJ, Qian J, Drewnowska KP, Kaminetsky JC, Huisman TK, Bilowus ML, Freedman SJ, Glover WL, Bostwick DG. Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases. J Urol. 2012 Nov; 188(5):1726-31.
    View in: PubMed
    Score: 0.004
  43. Oberley-Deegan RE, Steffan JJ, Rove KO, Pate KM, Weaver MW, Spasojevic I, Frederick B, Raben D, Meacham RB, Crapo JD, Koul HK. The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation. PLoS One. 2012; 7(9):e44178.
    View in: PubMed
    Score: 0.004
  44. Crawford ED, Moul JW, Rove KO, Pettaway CA, Lamerato LE, Hughes A. Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone. BJU Int. 2011 Dec; 108(11):1743-9.
    View in: PubMed
    Score: 0.003
  45. Barqawi AB, Rove KO, Gholizadeh S, O'Donnell CI, Koul H, Crawford ED. The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer. J Urol. 2011 Jul; 186(1):80-5.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)